HomeTagsRivus Pharmaceuticals

Rivus Pharmaceuticals

Biotechnology

Rivus Pharmaceuticals Appoints Jorge Bartolome as Chief Executive Officer

News Desk - February 27, 2026

Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to treating MASH, obesity, and associated cardiometabolic diseases, announced the appointment of Jorge Bartolome as Chief...

Biotechnology

Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6 for the Treatment

PR Newswire - September 23, 2022

Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, announced the completion of a $132 million Series B financing led by...